{"entity":{"type":"insider","cik":"0001431437","url":"/insider/0001431437","json_url":"/insider/0001431437.json","name":"Clarus Ventures II, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":23,"first":"2008-09-09","last":"2018-09-19","span_basis":"filed_date"},"name_variants":[{"name":"Clarus Ventures II, LLC","source":"filing","n_filings":23,"first_seen":"2008-09-09","last_seen":"2018-09-19"}],"transactions":[{"id":6460195,"accession":"0001401708-18-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001401708-18-000122","line_url":"/filing/0001401708-18-000122#line-1","is_derivative":false,"issuer_cik":"0001401708","issuer_name":"NanoString Technologies Inc","issuer_ticker":"NSTG","issuer_name_source":null,"issuer_url":"/issuer/0001401708","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC; Clarus Ventures II GP, L.P.","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85823.0,"shares_display":"85,823","price_per_share":15.99,"price_display":"15.99","price_state":"stated","total_value":1372309.77,"total_display":"1,372,309.77","total_whole":"1,372,310","shares_owned_after":4036025.0,"shares_owned_after_display":"4,036,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-19","scope":"insider"},{"id":2503803,"accession":"0001012975-16-000991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-000991","line_url":"/filing/0001012975-16-000991#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; LIPTAK ROBERT; WHEELER KURT; HENNER DENNIS; Simon Nicholas; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230507.0,"shares_display":"230,507","price_per_share":0.16,"price_display":"0.16","price_state":"stated","total_value":36881.12,"total_display":"36,881.12","total_whole":"36,881","shares_owned_after":2214523.0,"shares_owned_after_display":"2,214,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-09","filed_date":"2016-02-10","scope":"insider"},{"id":2503797,"accession":"0001012975-16-000991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-16-000991","line_url":"/filing/0001012975-16-000991#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; LIPTAK ROBERT; WHEELER KURT; HENNER DENNIS; Simon Nicholas; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103123.0,"shares_display":"103,123","price_per_share":0.19,"price_display":"0.19","price_state":"stated","total_value":19593.37,"total_display":"19,593.37","total_whole":"19,593","shares_owned_after":2445030.0,"shares_owned_after_display":"2,445,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-08","filed_date":"2016-02-10","scope":"insider"},{"id":3355598,"accession":"0001012975-16-000980","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-16-000980","line_url":"/filing/0001012975-16-000980#line-3","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; WHEELER KURT; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":832881.0,"shares_display":"832,881","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":166576.2,"total_display":"166,576.20","total_whole":"166,576","shares_owned_after":2548153.0,"shares_owned_after_display":"2,548,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-05","filed_date":"2016-02-05","scope":"insider"},{"id":3355595,"accession":"0001012975-16-000980","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-000980","line_url":"/filing/0001012975-16-000980#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; WHEELER KURT; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500026.0,"shares_display":"500,026","price_per_share":0.14,"price_display":"0.14","price_state":"stated","total_value":70003.64,"total_display":"70,003.64","total_whole":"70,004","shares_owned_after":3381034.0,"shares_owned_after_display":"3,381,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-04","filed_date":"2016-02-05","scope":"insider"},{"id":3355591,"accession":"0001012975-16-000980","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-16-000980","line_url":"/filing/0001012975-16-000980#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; WHEELER KURT; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82583.0,"shares_display":"82,583","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":12387.45,"total_display":"12,387.45","total_whole":"12,387","shares_owned_after":3881060.0,"shares_owned_after_display":"3,881,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-03","filed_date":"2016-02-05","scope":"insider"},{"id":2503793,"accession":"0001012975-16-000957","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-16-000957","line_url":"/filing/0001012975-16-000957#line-3","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; Simon Nicholas; GALAKATOS NICHOLAS; WHEELER KURT; Clarus Ventures II, LLC; STEINMETZ MICHAEL","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":176306.0,"shares_display":"176,306","price_per_share":0.17,"price_display":"0.17","price_state":"stated","total_value":29972.02,"total_display":"29,972.02","total_whole":"29,972","shares_owned_after":3963643.0,"shares_owned_after_display":"3,963,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-02","filed_date":"2016-02-02","scope":"insider"},{"id":2503787,"accession":"0001012975-16-000957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-000957","line_url":"/filing/0001012975-16-000957#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; Simon Nicholas; GALAKATOS NICHOLAS; WHEELER KURT; Clarus Ventures II, LLC; STEINMETZ MICHAEL","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140000.0,"shares_display":"140,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":28000.0,"total_display":"28,000.00","total_whole":"28,000","shares_owned_after":4139949.0,"shares_owned_after_display":"4,139,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-01","filed_date":"2016-02-02","scope":"insider"},{"id":2503780,"accession":"0001012975-16-000957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-16-000957","line_url":"/filing/0001012975-16-000957#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; Simon Nicholas; GALAKATOS NICHOLAS; WHEELER KURT; Clarus Ventures II, LLC; STEINMETZ MICHAEL","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52826.0,"shares_display":"52,826","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":13734.76,"total_display":"13,734.76","total_whole":"13,735","shares_owned_after":4279949.0,"shares_owned_after_display":"4,279,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-29","filed_date":"2016-02-02","scope":"insider"},{"id":2864990,"accession":"0001012975-16-000938","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-16-000938","line_url":"/filing/0001012975-16-000938#line-3","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; WHEELER KURT; Simon Nicholas; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; GALAKATOS NICHOLAS; LIPTAK ROBERT; Clarus Ventures II, LLC","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32521.0,"shares_display":"32,521","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":8455.46,"total_display":"8,455.46","total_whole":"8,455","shares_owned_after":4332775.0,"shares_owned_after_display":"4,332,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-28","filed_date":"2016-01-28","scope":"insider"},{"id":2864986,"accession":"0001012975-16-000938","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-000938","line_url":"/filing/0001012975-16-000938#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; WHEELER KURT; Simon Nicholas; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; GALAKATOS NICHOLAS; LIPTAK ROBERT; Clarus Ventures II, LLC","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":209984.0,"shares_display":"209,984","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":56695.68,"total_display":"56,695.68","total_whole":"56,696","shares_owned_after":4365296.0,"shares_owned_after_display":"4,365,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-27","filed_date":"2016-01-28","scope":"insider"},{"id":2864979,"accession":"0001012975-16-000938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-16-000938","line_url":"/filing/0001012975-16-000938#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; WHEELER KURT; Simon Nicholas; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; GALAKATOS NICHOLAS; LIPTAK ROBERT; Clarus Ventures II, LLC","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69425.0,"shares_display":"69,425","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":20827.5,"total_display":"20,827.50","total_whole":"20,828","shares_owned_after":4575280.0,"shares_owned_after_display":"4,575,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-26","filed_date":"2016-01-28","scope":"insider"},{"id":8657040,"accession":"0001104659-15-049019","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-15-049019","line_url":"/filing/0001104659-15-049019#line-3","is_derivative":false,"issuer_cik":"0001431437","issuer_name":"CATABASIS PHARMACEUTICALS INC","issuer_ticker":"CATB","issuer_name_source":null,"issuer_url":"/issuer/0001431437","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; Clarus Ventures II GP, L.P.; Clarus Ventures II, LLC","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":376695.0,"shares_display":"376,695","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4520340.0,"total_display":"4,520,340.00","total_whole":"4,520,340","shares_owned_after":2752488.0,"shares_owned_after_display":"2,752,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-30","filed_date":"2015-06-30","scope":"insider"},{"id":8856842,"accession":"0001012975-15-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000017","line_url":"/filing/0001012975-15-000017#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; WHEELER KURT; Clarus Ventures II GP, L.P.; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; GALAKATOS NICHOLAS; LIPTAK ROBERT; HENNER DENNIS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":175000.0,"shares_display":"175,000","price_per_share":31.11,"price_display":"31.11","price_state":"stated","total_value":5444250.0,"total_display":"5,444,250.00","total_whole":"5,444,250","shares_owned_after":3324259.0,"shares_owned_after_display":"3,324,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-12","scope":"insider"},{"id":8171532,"accession":"0001012975-15-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000003","line_url":"/filing/0001012975-15-000003","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"STEINMETZ MICHAEL; Simon Nicholas; HENNER DENNIS; WHEELER KURT; Clarus Ventures II GP, L.P.; Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS","owner_display_name":"STEINMETZ MICHAEL","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23620.0,"shares_display":"23,620","price_per_share":30.860008467400508,"price_display":"30.86","price_state":"stated","total_value":728913.4,"total_display":"728,913.40","total_whole":"728,913","shares_owned_after":3509459.0,"shares_owned_after_display":"3,509,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-05","filed_date":"2015-01-06","scope":"insider","n_lines":2},{"id":6925879,"accession":"0001012975-14-000835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-14-000835","line_url":"/filing/0001012975-14-000835#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; WHEELER KURT; Clarus Ventures II GP, L.P.; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; GALAKATOS NICHOLAS; LIPTAK ROBERT; HENNER DENNIS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6214.0,"shares_display":"6,214","price_per_share":30.03,"price_display":"30.03","price_state":"stated","total_value":186606.42,"total_display":"186,606.42","total_whole":"186,606","shares_owned_after":3522879.0,"shares_owned_after_display":"3,522,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-29","filed_date":"2014-12-30","scope":"insider"},{"id":6925876,"accession":"0001012975-14-000835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-14-000835","line_url":"/filing/0001012975-14-000835#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; WHEELER KURT; Clarus Ventures II GP, L.P.; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; GALAKATOS NICHOLAS; LIPTAK ROBERT; HENNER DENNIS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74510.0,"shares_display":"74,510","price_per_share":30.05,"price_display":"30.05","price_state":"stated","total_value":2239025.5,"total_display":"2,239,025.50","total_whole":"2,239,026","shares_owned_after":3529093.0,"shares_owned_after_display":"3,529,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-26","filed_date":"2014-12-30","scope":"insider"},{"id":6275897,"accession":"0001012975-14-000826","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-14-000826","line_url":"/filing/0001012975-14-000826#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"HENNER DENNIS; Clarus Lifesciences II, L.P.; STEINMETZ MICHAEL; Clarus Ventures II, LLC; Clarus Ventures II GP, L.P.; Simon Nicholas; WHEELER KURT; GALAKATOS NICHOLAS; LIPTAK ROBERT","owner_display_name":"HENNER DENNIS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":263.0,"shares_display":"263","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":7890.0,"total_display":"7,890.00","total_whole":"7,890","shares_owned_after":3603603.0,"shares_owned_after_display":"3,603,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-23","filed_date":"2014-12-24","scope":"insider"},{"id":6275894,"accession":"0001012975-14-000826","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-14-000826","line_url":"/filing/0001012975-14-000826#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"HENNER DENNIS; Clarus Lifesciences II, L.P.; STEINMETZ MICHAEL; Clarus Ventures II, LLC; Clarus Ventures II GP, L.P.; Simon Nicholas; WHEELER KURT; GALAKATOS NICHOLAS; LIPTAK ROBERT","owner_display_name":"HENNER DENNIS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49441.0,"shares_display":"49,441","price_per_share":30.36,"price_display":"30.36","price_state":"stated","total_value":1501028.76,"total_display":"1,501,028.76","total_whole":"1,501,029","shares_owned_after":3603866.0,"shares_owned_after_display":"3,603,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-22","filed_date":"2014-12-24","scope":"insider"},{"id":6544138,"accession":"0001012975-14-000396","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001012975-14-000396","line_url":"/filing/0001012975-14-000396","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Ventures II GP, L.P.; WHEELER KURT; Simon Nicholas; LIPTAK ROBERT; Clarus Lifesciences II, L.P.; HENNER DENNIS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29717.0,"shares_display":"29,717","price_per_share":44.52784311336945,"price_display":"44.53","price_state":"stated","total_value":1323233.9138,"total_display":"1,323,233.91","total_whole":"1,323,234","shares_owned_after":2843564.0,"shares_owned_after_display":"2,843,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-11","filed_date":"2014-06-11","scope":"insider","n_lines":2},{"id":6544132,"accession":"0001012975-14-000396","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001012975-14-000396","line_url":"/filing/0001012975-14-000396","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Ventures II GP, L.P.; WHEELER KURT; Simon Nicholas; LIPTAK ROBERT; Clarus Lifesciences II, L.P.; HENNER DENNIS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":116904.0,"shares_display":"116,904","price_per_share":45.05386866488743,"price_display":"45.05","price_state":"stated","total_value":5266977.4624,"total_display":"5,266,977.46","total_whole":"5,266,977","shares_owned_after":2909861.0,"shares_owned_after_display":"2,909,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-10","filed_date":"2014-06-11","scope":"insider","n_lines":3},{"id":6544122,"accession":"0001012975-14-000396","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-14-000396","line_url":"/filing/0001012975-14-000396","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Ventures II GP, L.P.; WHEELER KURT; Simon Nicholas; LIPTAK ROBERT; Clarus Lifesciences II, L.P.; HENNER DENNIS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65059.0,"shares_display":"65,059","price_per_share":46.48031590709971,"price_display":"46.48","price_state":"stated","total_value":3023962.8726,"total_display":"3,023,962.87","total_whole":"3,023,963","shares_owned_after":2989685.0,"shares_owned_after_display":"2,989,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-09","filed_date":"2014-06-11","scope":"insider","n_lines":2},{"id":5332656,"accession":"0001192482-13-000240","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001192482-13-000240","line_url":"/filing/0001192482-13-000240#line-3","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Ventures II GP, L.P.; WHEELER KURT; HENNER DENNIS; Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC; LIPTAK ROBERT; GALAKATOS NICHOLAS; STEINMETZ MICHAEL; Simon Nicholas","owner_display_name":"Clarus Ventures II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1425063.0,"shares_display":"1,425,063","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":9975441.0,"total_display":"9,975,441.00","total_whole":"9,975,441","shares_owned_after":1425063.0,"shares_owned_after_display":"1,425,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-17","filed_date":"2013-12-19","scope":"insider"},{"id":9215334,"accession":"0001012975-15-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000076","line_url":"/filing/0001012975-15-000076#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; Clarus Ventures II GP, L.P.; Clarus Ventures II, LLC; GALAKATOS NICHOLAS; HENNER DENNIS; LIPTAK ROBERT; STEINMETZ MICHAEL; Simon Nicholas; WHEELER KURT","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":321000.0,"shares_display":"321,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3210000.0,"total_display":"3,210,000.00","total_whole":"3,210,000","shares_owned_after":3468494.0,"shares_owned_after_display":"3,468,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-25","filed_date":"2015-01-30","scope":"insider"},{"id":5556878,"accession":"0001012975-13-000497","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-13-000497","line_url":"/filing/0001012975-13-000497#line-4","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"STEINMETZ MICHAEL; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures II GP, L.P.","owner_display_name":"STEINMETZ MICHAEL","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":321000.0,"shares_display":"321,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3210000.0,"total_display":"3,210,000.00","total_whole":"3,210,000","shares_owned_after":3653306.0,"shares_owned_after_display":"3,653,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-25","filed_date":"2013-10-28","scope":"insider"},{"id":4939823,"accession":"0001209191-13-034478","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-034478","line_url":"/filing/0001209191-13-034478#line-4","is_derivative":false,"issuer_cik":"0001401708","issuer_name":"NanoString Technologies Inc","issuer_ticker":"NSTG","issuer_name_source":null,"issuer_url":"/issuer/0001401708","owner_cik":null,"owner_name":"Clarus Ventures II GP, L.P.; Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC","owner_display_name":"Clarus Ventures II GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":7500000.0,"total_display":"7,500,000.00","total_whole":"7,500,000","shares_owned_after":3959440.0,"shares_owned_after_display":"3,959,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-01","scope":"insider"},{"id":3539893,"accession":"0001012975-12-000163","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-12-000163","line_url":"/filing/0001012975-12-000163","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II, LLC; WHEELER KURT; Clarus Lifesciences II, L.P.; STEINMETZ MICHAEL; Simon Nicholas; Clarus Ventures II GP, L.P.","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1316956.0,"shares_display":"1,316,956","price_per_share":7.4932,"price_display":"7.49","price_state":"stated","total_value":9868214.6992,"total_display":"9,868,214.70","total_whole":"9,868,215","shares_owned_after":10942471.0,"shares_owned_after_display":"10,942,471","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-31","filed_date":"2012-06-04","scope":"insider","n_lines":2},{"id":7624096,"accession":"0001012975-10-000292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000292","line_url":"/filing/0001012975-10-000292#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; Simon Nicholas; WHEELER KURT; Clarus Ventures II GP, L.P.; HENNER DENNIS; GALAKATOS NICHOLAS; LIPTAK ROBERT; STEINMETZ MICHAEL; Leiden Jeffrey","owner_display_name":"Clarus Ventures II, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4875502.0,"shares_display":"4,875,502","price_per_share":2.49,"price_display":"2.49","price_state":"stated","total_value":12139999.98,"total_display":"12,139,999.98","total_whole":"12,140,000","shares_owned_after":9262079.0,"shares_owned_after_display":"9,262,079","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-20","filed_date":"2010-08-20","scope":"insider"},{"id":7378352,"accession":"0001012975-10-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000008","line_url":"/filing/0001012975-10-000008#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Clarus Ventures II, LLC; Leiden Jeffrey; STEINMETZ MICHAEL; WHEELER KURT; Clarus Lifesciences II, L.P.; Simon Nicholas; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233990.0,"shares_display":"233,990","price_per_share":3.7667,"price_display":"3.77","price_state":"stated","total_value":881370.133,"total_display":"881,370.13","total_whole":"881,370","shares_owned_after":4386577.0,"shares_owned_after_display":"4,386,577","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-13","scope":"insider"},{"id":7761173,"accession":"0001012975-10-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-10-000002","line_url":"/filing/0001012975-10-000002#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; LIPTAK ROBERT; HENNER DENNIS; WHEELER KURT; Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; Leiden Jeffrey; Simon Nicholas","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":12600.0,"total_display":"12,600.00","total_whole":"12,600","shares_owned_after":4620567.0,"shares_owned_after_display":"4,620,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-07","filed_date":"2010-01-08","scope":"insider"},{"id":7761172,"accession":"0001012975-10-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000002","line_url":"/filing/0001012975-10-000002#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; LIPTAK ROBERT; HENNER DENNIS; WHEELER KURT; Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; Leiden Jeffrey; Simon Nicholas","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49400.0,"shares_display":"49,400","price_per_share":3.5027,"price_display":"3.50","price_state":"stated","total_value":173033.38,"total_display":"173,033.38","total_whole":"173,033","shares_owned_after":4624167.0,"shares_owned_after_display":"4,624,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-06","filed_date":"2010-01-08","scope":"insider"},{"id":5686692,"accession":"0001012975-09-000362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-09-000362","line_url":"/filing/0001012975-09-000362#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"HENNER DENNIS; WHEELER KURT; Simon Nicholas; LIPTAK ROBERT; Clarus Lifesciences II, L.P.; STEINMETZ MICHAEL; GALAKATOS NICHOLAS; Clarus Ventures II, LLC; Leiden Jeffrey; Clarus Ventures II GP, L.P.","owner_display_name":"HENNER DENNIS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":3.5264,"price_display":"3.53","price_state":"stated","total_value":12695.04,"total_display":"12,695.04","total_whole":"12,695","shares_owned_after":4673567.0,"shares_owned_after_display":"4,673,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-24","filed_date":"2009-12-29","scope":"insider"},{"id":5678134,"accession":"0001012975-09-000360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-09-000360","line_url":"/filing/0001012975-09-000360#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Leiden Jeffrey; Clarus Ventures II GP, L.P.; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; LIPTAK ROBERT","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":264900.0,"shares_display":"264,900","price_per_share":3.7049,"price_display":"3.70","price_state":"stated","total_value":981428.01,"total_display":"981,428.01","total_whole":"981,428","shares_owned_after":4677167.0,"shares_owned_after_display":"4,677,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2009-12-23","scope":"insider"},{"id":5678133,"accession":"0001012975-09-000360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-09-000360","line_url":"/filing/0001012975-09-000360#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Leiden Jeffrey; Clarus Ventures II GP, L.P.; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; LIPTAK ROBERT","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19100.0,"shares_display":"19,100","price_per_share":3.5426,"price_display":"3.54","price_state":"stated","total_value":67663.66,"total_display":"67,663.66","total_whole":"67,664","shares_owned_after":4942067.0,"shares_owned_after_display":"4,942,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-21","filed_date":"2009-12-23","scope":"insider"},{"id":5775261,"accession":"0001012975-09-000358","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-09-000358","line_url":"/filing/0001012975-09-000358#line-3","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Leiden Jeffrey; STEINMETZ MICHAEL; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures II GP, L.P.","owner_display_name":"Leiden Jeffrey","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9900.0,"shares_display":"9,900","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":34650.0,"total_display":"34,650.00","total_whole":"34,650","shares_owned_after":4961167.0,"shares_owned_after_display":"4,961,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-18","filed_date":"2009-12-18","scope":"insider"},{"id":5775260,"accession":"0001012975-09-000358","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-09-000358","line_url":"/filing/0001012975-09-000358#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Leiden Jeffrey; STEINMETZ MICHAEL; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures II GP, L.P.","owner_display_name":"Leiden Jeffrey","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129476.0,"shares_display":"129,476","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":453166.0,"total_display":"453,166.00","total_whole":"453,166","shares_owned_after":4971067.0,"shares_owned_after_display":"4,971,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-17","filed_date":"2009-12-18","scope":"insider"},{"id":5775259,"accession":"0001012975-09-000358","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-09-000358","line_url":"/filing/0001012975-09-000358#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Leiden Jeffrey; STEINMETZ MICHAEL; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures II GP, L.P.","owner_display_name":"Leiden Jeffrey","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67800.0,"shares_display":"67,800","price_per_share":3.5768,"price_display":"3.58","price_state":"stated","total_value":242507.04,"total_display":"242,507.04","total_whole":"242,507","shares_owned_after":5100543.0,"shares_owned_after_display":"5,100,543","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-16","filed_date":"2009-12-18","scope":"insider"},{"id":3124728,"accession":"0001012975-08-000149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-08-000149","line_url":"/filing/0001012975-08-000149#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Leiden Jeffrey; Simon Nicholas; HENNER DENNIS; WHEELER KURT; Clarus Ventures II GP, L.P.; LIPTAK ROBERT; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Leiden Jeffrey","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":2.3694,"price_display":"2.37","price_state":"stated","total_value":3791.04,"total_display":"3,791.04","total_whole":"3,791","shares_owned_after":5307420.0,"shares_owned_after_display":"5,307,420","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-09","scope":"insider"},{"id":3124725,"accession":"0001012975-08-000149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-08-000149","line_url":"/filing/0001012975-08-000149#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Leiden Jeffrey; Simon Nicholas; HENNER DENNIS; WHEELER KURT; Clarus Ventures II GP, L.P.; LIPTAK ROBERT; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Leiden Jeffrey","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3054.0,"shares_display":"3,054","price_per_share":2.1917,"price_display":"2.19","price_state":"stated","total_value":6693.4518,"total_display":"6,693.45","total_whole":"6,693","shares_owned_after":5305820.0,"shares_owned_after_display":"5,305,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-09-05","filed_date":"2008-09-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001401708","name":"NanoString Technologies Inc","url":"/issuer/0001401708","role":"Ten percent owner","n_filings":2,"first_seen":"2013-07-01","last_seen":"2018-09-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001361248","name":"TETRALOGIC PHARMACEUTICALS CORP","url":"/issuer/0001361248","role":"Ten percent owner","n_filings":5,"first_seen":"2013-12-19","last_seen":"2016-02-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001454789","name":"CATABASIS PHARMACEUTICALS INC","url":"/issuer/0001454789","role":"Ten percent owner","n_filings":1,"first_seen":"2015-06-30","last_seen":"2015-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001337553","name":"AERIE PHARMACEUTICALS INC","url":"/issuer/0001337553","role":"Ten percent owner","n_filings":6,"first_seen":"2013-10-28","last_seen":"2015-01-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001410939","name":"Ophthotech Corp.","url":"/issuer/0001410939","role":"Ten percent owner","n_filings":1,"first_seen":"2014-06-11","last_seen":"2014-06-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001070336","name":"ACHILLION PHARMACEUTICALS INC","url":"/issuer/0001070336","role":"Ten percent owner","n_filings":8,"first_seen":"2008-09-09","last_seen":"2012-06-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001431437","retrieved_at":"2026-08-26T23:28:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}